相关实验视频
Updated: Sep 10, 2025
12:36
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
16.3K
克劳丁-1 是原发性硬化胆炎的调解剂和治疗点
Fabio Del Zompo1, Emilie Crouchet1, Tessa Ostyn2
1Inserm U1110, Institute of Translational Medicine and Liver Diseases (ITM), University of Strasbourg, Strasbourg, France.
Journal of hepatology
|August 22, 2025
概括
克劳丁-1 (CLDN1) 是原发性硬化胆道炎 (PSC) 发病的一个关键媒介. 通过单克隆抗体向CLDN1,可通过减少肝纤维化和胆固醇形成来治疗PSC.
科学领域:
- 肝病学和免疫学
- 分子和细胞生物学
- 转化医学
背景情况:
- 原发性硬化性胆道炎 (PSC) 是一种严重的肝病,治疗选择有限,往往会发展为末期肝病和癌症.
- 目前尚不清楚PSC的潜在机制,因此需要新的治疗点.
- 克劳丁-1 (CLDN1) 是肝脏上皮细胞中细胞通信至关重要的蛋白质,研究了其在PSC中的作用.
研究的目的:
- 阐明Claudin-1 (CLDN1) 在原发性硬化性胆道炎 (PSC) 发病过程中的功能作用.
- 使用临床前模型评估CLDN1作为PSC的潜在治疗点.
- 评估CLDN1特异性单克隆抗体 (mAbs) 在治疗PSC相关的肝损伤中的有效性.
主要方法:
- 使用scRNAseq,空间转录组和多重组蛋白组对PSC患者肝脏组织中的CLDN1表达模式进行分析.
- 在小鼠PSC和胆血管病例模型中进行了涉及CLDN1特异性单克隆抗体 (mAbs) 和遗传功能丧失的概念验证研究.
- 使用基于人类细胞的模型进行机制研究,以了解CLDN1在疾病途径中的作用.
主要成果:
- 在PSC肝组织中,CLDN1表达显著上调,与疾病进展相关.
- 在患病的胆血管细胞和肝细胞中观察到高CLDN1表达,与亲炎和亲纤维信号相关.
- 在PSC小鼠模型中,治疗CLDN1特异性mAbs或基因淘汰改善了肝纤维化和胆固醇化.
- 在相关细胞类型中,mAb治疗有效抑制了促炎和促纤维信号传递.
结论:
- 克劳丁-1 (CLDN1) 在原发性硬化性胆道炎 (PSC) 和胆道纤维化病变中起着关键的功能作用.
- 临床前研究表明CLDN1特异性单克隆抗体 (mAbs) 作为PSC治疗策略的潜力.
- 这些发现支持对PSC患者进行临床向CLDN1治疗.
相关概念视频
01:17Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
01:24Chronic Pancreatitis I: Introduction
148
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
148
01:29Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
231
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
231
01:29Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189
01:17Gastritis-II: Pathophysiology
543
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
543